Austco Healthcare increases revenues by 11%, further investment in R&D and accelerates direct to market capabilities in Australia
-
Accumulated orders yet to be delivered grow to an all-time high of $44.4 million
-
Revenue from customers up 11% to $22.8 million
-
Software and SMA revenues up 11% to $4.0 million
-
Gross Margins decreased to 51.9% compared to 54.8%
-
NPAT down from $1.4 million pcp to $1.2 million due to investment in strategic growth initiatives
-
Teknocorp acquisition completed and a term sheet for the acquisition of Amentco announced
Austco Healthcare Limited (ASX:AHC), a global leader in clinical communications solutions, is pleased to announce an 11% surge in revenue from customers over the prior comparative period (pcp), reaching $22.8 million for 1HFY24. This achievement underscores the company's continued growth trajectory and commitment to delivering innovative solutions to healthcare providers globally.
For more information, download the attached PDF.
Download this document
